NPPTL COVID-19 Response, International Assessment-Not NIOSH Approved, Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

NPPTL COVID-19 Response, International Assessment-Not NIOSH Approved, Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501

07/30/2020

[PDF-2.60 MB]

Details You May Also Like

Details:

Description:

These findings pertain to the Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501. The packaging for this product indicates that it meets GB2626-2006 standards.
Document Type:

Report
CIO:

NIOSH
Division:

NIOSH_NPPTL
Collection(s):

Historical CDC.gov Content
Main Document Checksum:

[+]

urn:sha256:059332777e50b5a46a3d27fee420d5627575b9ffe0682261802f4491e0f19d05
Download URL:

https://stacks.cdc.gov/view/cdc/137950/cdc_137950_DS1.pdf
File Type:

No Additional Files

More +

NPPTL COVID-19 Response, International Assessment-Not NIOSH Approved, Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501

Details:

Supporting Files

You May Also Like